1.
Seroprevalence of Borrelia burgdorferi in Belgian forestry workers and associated risk factors.
2.
3.
4.
5.
6.
7.
Individual and environmental factors associated with the seroprevalence of Borrelia burgdorferi in Belgian farmers and veterinarians
Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.
A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium.
Prevalence of chronic hepatitis E infection in immunosuppressed patients in Belgium.
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
Surveillance of Infectious Diseases by the Sentinel Laboratory Network in Belgium: 30 Years of Continuous Improvement.
The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.